Maximilian Salcher-Konrad

Maximilian Salcher-Konrad

PhD candidate

Department of Health Policy

Key Expertise
drug marketing authorisation

About me

Maximilian is a Research Officer within CPEC and LSE Health and a part-time PhD student in the Department of Health Policy at LSE. He holds an MSc in Health Policy, Planning and Financing from LSE and the London School of Hygiene and Tropical Medicine and a BSc in Business, Economics and Social Sciences from the Vienna University of Economics and Business (WU).


Maximilian’s PhD research focuses on evidence requirements for drug marketing authorisation, critically reviewing recent developments in medicines regulation aimed at accelerating market approval for new medicines.

Maximilian empirically evaluates the assumptions underpinning expedited approval programmes such as conditional marketing authorisation in the EU and accelerated approval in the US, and focuses in particular on the use of non-randomised studies to provide evidence on the efficacy of new medicines.


Expertise Details

drug marketing authorisation